Journals
Publish with us
Publishing partnerships
About us
Blog
International Scholarly Research Notices
Table of Contents
International Scholarly Research Notices
/
2013
/
Article
/
Tab 3
/
Clinical Study
Oxaliplatin and Bolus-Modulated 5-Fluorouracil as a Second-Line Treatment for Advanced Pancreatic Cancer: Can Bolus Regimens Replace FOLFOX When Considered for Second Line?
Table 3
Summarizing efficacy results of the 2 regimens.
ā
FLOX arm
3-week arm
value
Partial responses
3 (12.5%)
2 (16%)
.23
Stable disease
5 (21%)
5 (21%)
.5
Clinical benefit
3/8 (37.5%)
4/8 (50%)
.19